We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-10.56%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.98B
AUM Growth
-$122M
Cap. Flow
+$122M
Cap. Flow %
6.17%
Top 10 Hldgs %
22.19%
Holding
209
New
50
Increased
69
Reduced
49
Closed
37

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$52.1M
2
WBD icon
Warner Bros
WBD
+$34M
3
VTRS icon
Viatris
VTRS
+$33.3M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$28.3M
5
AKAM icon
Akamai
AKAM
+$27.8M

Top Sells

Rank Stock Value
1
TAP icon
Molson Coors Class B
TAP
+$37.4M
2
ES icon
Eversource Energy
ES
+$34.8M
3
T icon
AT&T
T
+$30M
4
SSNC icon
SS&C Technologies
SSNC
+$28M
5
PGNY icon
Progyny
PGNY
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 22.24%
2 Consumer Discretionary 18.14%
3 Healthcare 12.54%
4 Industrials 8.78%
5 Communication Services 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLGT icon
126
Fulgent Genetics
FLGT
$524M
$3.99M 0.2%
236,172
-22,838
-9% -$389K
VC icon
127
Visteon
VC
$2.8B
$3.95M 0.2%
+50,859
New +$4.28M
SEAT icon
128
Vivid Seats
SEAT
$82.6M
$3.82M 0.19%
64,605
-15,156
-19% -$1.22M
BXC icon
129
BlueLinx
BXC
$719M
$3.62M 0.18%
+48,228
New +$4.48M
ALGN icon
130
Align Technology
ALGN
$12.5B
$3.58M 0.18%
+22,506
New +$4.42M
MLKN icon
131
MillerKnoll
MLKN
$1.64B
$3.51M 0.18%
183,541
+86,083
+88% +$1.83M
SNV
132
PUT
DELISTED
Synovus
SNV
$3.51M 0.18%
75,000
BL icon
133
BlackLine
BL
$1.7B
$3.47M 0.18%
+71,592
New +$3.92M
RSKD icon
134
Riskified
RSKD
$712M
$3.26M 0.16%
705,774
-175,012
-20% -$882K
CENTA icon
135
Central Garden & Pet Co Class A
CENTA
$2.39B
$3.22M 0.16%
+98,484
New +$3.13M
TROX icon
136
Tronox
TROX
$993M
$3.17M 0.16%
450,882
+241,024
+115% +$2.07M
OEC icon
137
Orion
OEC
$389M
$3.13M 0.16%
+241,707
New +$3.42M
CFG icon
138
PUT
Citizens Financial Group
CFG
$30.6B
$3.07M 0.16%
75,000
SMP icon
139
Standard Motor Products
SMP
$885M
$3.04M 0.15%
122,088
+31,244
+34% +$917K
SPT icon
140
Sprout Social
SPT
$609M
$3.03M 0.15%
+137,991
New +$4.01M
FORR icon
141
Forrester Research
FORR
$221M
$2.98M 0.15%
322,163
+160,569
+99% +$2.04M
VPG icon
142
Vishay Precision Group
VPG
$864M
$2.91M 0.15%
120,633
+68,260
+130% +$1.59M
WHR icon
143
Whirlpool
WHR
$2.75B
$2.84M 0.14%
+31,501
New +$3.34M
BKD icon
144
Brookdale Senior Living
BKD
$3.27B
$2.73M 0.14%
+436,170
New +$2.33M
BTG icon
145
B2Gold
BTG
$6.68B
$2.49M 0.13%
872,494
-243,995
-22% -$655K
AVD icon
146
American Vanguard Corp
AVD
$65.5M
$2.44M 0.12%
555,069
-88,023
-14% -$449K
UFI icon
147
UNIFI
UFI
$129M
$2.41M 0.12%
500,832
-12,182
-2% -$68.3K
EMN icon
148
Eastman Chemical
EMN
$8.39B
$2.39M 0.12%
27,128
-7,660
-22% -$723K
HURC icon
149
Hurco Companies Inc
HURC
$141M
$2.27M 0.11%
146,326
-3,531
-2% -$67.2K
ACHC icon
150
Acadia Healthcare
ACHC
$2.96B
$2.18M 0.11%
+71,779
New +$2.73M

Similar funds

Invenomic Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Invenomic Capital Management held 209 positions worth $1.98B, down 5.8% from $2.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Invenomic Capital Management deployed $122M of net new capital in Q1 2025, opening 50 new positions and adding to 69 existing holdings. Its largest new stake was Warner Bros: 3,254,123 shares worth $34.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Eversource Energy, an estimated $34.8M trimmed.

  • Invenomic Capital Management's largest Q1 2025 buy was Warner Bros: 3,254,123 shares worth $34.9M.
  • Invenomic Capital Management added most to Teleflex in Q1 2025, an estimated $52.1M increase.
  • Invenomic Capital Management's biggest Q1 2025 reduction was Eversource Energy, cutting an estimated $34.8M.
  • Invenomic Capital Management fully exited Molson Coors Class B in Q1 2025, selling an estimated $37.4M.
  • Invenomic Capital Management's ten largest holdings make up 22% of its $1.98B portfolio in Q1 2025.
  • Invenomic Capital Management opened 50 new positions and closed 37 in Q1 2025.
  • Invenomic Capital Management's portfolio value fell 5.8% quarter-over-quarter to $1.98B.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.